AP2966A - Nanoparticle carriers for drug administration and process for producing same - Google Patents

Nanoparticle carriers for drug administration and process for producing same

Info

Publication number
AP2966A
AP2966A AP2010005389A AP2010005389A AP2966A AP 2966 A AP2966 A AP 2966A AP 2010005389 A AP2010005389 A AP 2010005389A AP 2010005389 A AP2010005389 A AP 2010005389A AP 2966 A AP2966 A AP 2966A
Authority
AP
ARIPO
Prior art keywords
drug administration
producing same
nanoparticle carriers
nanoparticle
carriers
Prior art date
Application number
AP2010005389A
Other languages
English (en)
Other versions
AP2010005389A0 (en
Inventor
Linji Kalombo
Original Assignee
Csir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csir filed Critical Csir
Publication of AP2010005389A0 publication Critical patent/AP2010005389A0/en
Application granted granted Critical
Publication of AP2966A publication Critical patent/AP2966A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Communicable Diseases (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AP2010005389A 2008-02-18 2008-02-18 Nanoparticle carriers for drug administration and process for producing same AP2966A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ZA2008/000012 WO2009105792A1 (en) 2008-02-18 2008-02-18 Nanoparticle carriers for drug administration and process for producing same

Publications (2)

Publication Number Publication Date
AP2010005389A0 AP2010005389A0 (en) 2010-10-31
AP2966A true AP2966A (en) 2014-09-30

Family

ID=39790304

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2010005389A AP2966A (en) 2008-02-18 2008-02-18 Nanoparticle carriers for drug administration and process for producing same

Country Status (15)

Country Link
US (1) US8518450B2 (de)
EP (1) EP2249817B8 (de)
JP (1) JP5575667B2 (de)
CN (1) CN101951895B (de)
AP (1) AP2966A (de)
AT (1) ATE537817T1 (de)
AU (1) AU2008351331B2 (de)
CA (1) CA2714429C (de)
DE (1) DE112008003727T5 (de)
ES (1) ES2397016B1 (de)
GB (1) GB2469965B (de)
HK (1) HK1145973A1 (de)
MX (1) MX2010008902A (de)
WO (1) WO2009105792A1 (de)
ZA (1) ZA201006639B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8815294B2 (en) * 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
TWI462753B (zh) * 2011-11-29 2014-12-01 Univ Nat Chiao Tung 雙乳化核殼奈米結構及其製備方法
EP2812104B1 (de) * 2012-02-07 2019-08-14 Centre National de la Recherche Scientifique (CNRS) Verfahren und vorrichtung zur herstellung von nanoteilchen durch blitzverdampfung
US9283298B2 (en) 2013-09-25 2016-03-15 Clemson University Compliant surgical adhesive
US9850521B2 (en) * 2014-08-01 2017-12-26 Agilent Technologies, Inc. In vitro assay buffer for Cas9
MA44833A (fr) * 2015-08-17 2018-06-27 Phosphorex Inc Nanoparticules extrêmement petites de polymères dégradables
CN108883076A (zh) * 2016-03-23 2018-11-23 胡哲铭 薄壳聚合物纳米粒子及其用途
EP3836900A1 (de) * 2018-08-17 2021-06-23 Smela, Krzysztof Pawel Mehrkammersystem vom nanokapsel-in-nanokapsel-typ zur einkapselung einer lipophilen und hydrophilen verbindung und entsprechendes herstellungsverfahren
CN109628547B (zh) * 2018-12-14 2022-02-25 陕西师范大学 一种改性磁珠、制备方法及其应用
WO2020229971A1 (en) * 2019-05-14 2020-11-19 Council For Scientific And Industrial Research Polymer-lipid nanocomplex for enhanced aqueous solubilisation and absorption of hydrophobic active compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003099262A1 (en) * 2002-05-28 2003-12-04 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the production of nanoparticles, wherein low mechanical and sonic energies are used simultaneously
EP1595549A1 (de) * 2003-02-19 2005-11-16 Takeda Pharmaceutical Company Limited Dispergens für zubereitungen mit verzögerter freisetzung

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US20040018236A1 (en) * 1995-05-08 2004-01-29 Robert Gurny Nanoparticles for oral administration of pharmaceutical agents of low solubility
IT1296914B1 (it) * 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
US7354886B2 (en) * 1999-07-29 2008-04-08 Baker Hughes Incorporated Pumpable multiple phase compositions for controlled release applications downhole
EP1267946A4 (de) * 2000-02-28 2008-07-02 Genesegues Inc Nanokapsel-einkapselungs-system und verfahren
DK1328612T3 (da) * 2000-10-27 2007-09-17 Genencor Int Partikel med substitueret polyvinylalkohol-coating
JP2003175092A (ja) * 2001-07-10 2003-06-24 Canon Inc ポリヒドロキシアルカノエートを含有する粒状体及びその製造方法ならびにその用途
EP1275378B1 (de) * 2001-07-10 2009-04-15 Canon Kabushiki Kaisha Partikel auf Basis von Polyhydroxyalkanoat und Verfahren zu deren Herstellung
ITTO20020452A1 (it) * 2002-05-29 2003-12-01 Vhit Spa Valvola pneumatica di limitazione del livello di depressione e sistema di frenatura comportante tale valvola.
JP5302888B2 (ja) * 2006-08-31 2013-10-02 エスケー ケミカルズ カンパニー リミテッド 薬物含有高分子微小球の製造方法及びその方法により製造された薬物含有高分子微小球
DE602007012559D1 (de) * 2006-09-08 2011-03-31 Univ Johns Hopkins H die schleimhaut

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003099262A1 (en) * 2002-05-28 2003-12-04 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the production of nanoparticles, wherein low mechanical and sonic energies are used simultaneously
EP1595549A1 (de) * 2003-02-19 2005-11-16 Takeda Pharmaceutical Company Limited Dispergens für zubereitungen mit verzögerter freisetzung

Also Published As

Publication number Publication date
EP2249817A1 (de) 2010-11-17
MX2010008902A (es) 2011-03-02
CN101951895B (zh) 2013-11-06
AU2008351331A1 (en) 2009-08-27
US20110033550A1 (en) 2011-02-10
CA2714429A1 (en) 2009-08-27
GB2469965A (en) 2010-11-03
EP2249817B1 (de) 2011-12-21
ATE537817T1 (de) 2012-01-15
DE112008003727T5 (de) 2011-04-21
AU2008351331B2 (en) 2014-07-17
CN101951895A (zh) 2011-01-19
JP5575667B2 (ja) 2014-08-20
US8518450B2 (en) 2013-08-27
HK1145973A1 (en) 2011-05-13
EP2249817B8 (de) 2012-03-21
GB201013546D0 (en) 2010-09-29
ZA201006639B (en) 2012-03-28
WO2009105792A1 (en) 2009-08-27
ES2397016A1 (es) 2013-03-04
AP2010005389A0 (en) 2010-10-31
GB2469965A8 (en) 2010-11-24
ES2397016B1 (es) 2014-01-17
GB2469965B (en) 2012-06-20
CA2714429C (en) 2015-04-28
JP2011512418A (ja) 2011-04-21

Similar Documents

Publication Publication Date Title
HK1145973A1 (en) Nanoparticle carriers for drug administration and process for producing same
EP2251050A4 (de) Katheter zur wirkstofffreisetzung und verfahren zur herstellung des katheters zur wirkstofffreisetzung
HK1160848A1 (en) Process for preparing chlorins and their pharmaceutical uses
PL2379132T3 (pl) Układ i sposób infuzji leku
IL216522A (en) Durable dosage form, packing containing it and method of preparation
EP2603900A4 (de) System und verfahren zur herstellung personalisierter arzneimittelprodukte
IL209419A0 (en) Modified drugs for use in liposomal nanoparticles
PL2273975T3 (pl) Roztwory farmaceutyczne, sposoby wytwarzania i zastosowania terapeutyczne
PL2299977T3 (pl) Liposomy do dostarczania leków i sposoby ich wytwarzania
HK1161878A1 (en) Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof
HUE043963T2 (hu) Morfinán származékok gyógyszer-túladagolás kezelésére
EP2351764A4 (de) Trehaloseverbindung, herstellungsverfahren und diese enthaltendes pharmazeutisches produkt
EP2601955A4 (de) Adsorptionsmittel zur oralen verabreichung, verfahren zu seiner herstellung und arzneimittel damit
HK1182656A1 (zh) 帶藥劑的支承體及其製造方法
EP2393486A4 (de) Aceclofenac-haltige orale arzneimittelpräparate mit kontrollierter freisetzung und ihr herstellungsverfahren
IL212603A0 (en) Combined drug administration
GB0707612D0 (en) Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
PL394863A1 (pl) Lek przeciwnowotworowy, sposób jego wytwarzania oraz sposób jego stabilizacji
IL219872A (en) Quinazoline derivatives, their uses, their preparation, and their medications
EP2612656A4 (de) Verfahren zur herstellung eines arzneimittel-blockcopolymer-verbundstoffs und pharmazeutisches produkt damit
GB0815179D0 (en) Medication and treatment for infection
TWI350178B (en) Magnetic nanoparticles for targeted hydrophobic drug delivery and their production method and application
IL190928A0 (en) Means and method for administering medicaments to infants
GB0810121D0 (en) Injection vehicle particles and prepartions for parenteral administration as well as process for their manufacture
GB0609588D0 (en) Nanoparticle Pharmaceutical Carrier